OBC paper.pdf (615.23 kB)
Scale-up and optimization of the synthesis of dual CBP/BRD4 inhibitor ISOX-DUAL
journal contribution
posted on 2023-06-10, 03:20 authored by Anthony Edmonds, Catherine S Oakes, Storm Hassell-HartStorm Hassell-Hart, Didier Bruyère, Graham J Tizzard, Simon J Coles, Robert Felix, Hannah J Maple, Graham P Marsh, John SpencerJohn SpencerISOX-DUAL is a dual inhibitor of CBP/p300 (IC50 = 0.65 µM) and BRD4 (IC50 = 1.5 µM) bromodomains, and a useful chemical probe for epigenetic research. Aspects of the published synthetic route to this compound and its analogues are small-scale, poor-yielding or simply unamenable to scale-up without optimization. Herein we describe the development of a refined synthesis that circumvents the challenges of the original report, with notable improvements to several of the key synthetic transformations. Moreover, a general Suzuki Miyaura protocol for the late stage installation of alternative dimethyl-isoxazole acetyl-lysine (KAc) binding motifs is presented.
History
Publication status
- Published
File Version
- Published version
Journal
Organic and Biomolecular ChemistryISSN
1477-0520Publisher
Royal Society of ChemistryExternal DOI
Department affiliated with
- Chemistry Publications
Full text available
- Yes
Peer reviewed?
- Yes
Legacy Posted Date
2022-05-05First Open Access (FOA) Date
2022-05-05First Compliant Deposit (FCD) Date
2022-05-04Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC